Pa Shun International Holdings Limited

574 KYG693781000

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
0.046 ^HKD	+4.55%		+9.52%	+48.39%

Apr. 03	Pa Shun International Holdings Names Chairman, CEO	MT
Apr. 02	Pa Shun International Holdings Limited Announces Board Appointments	CI

Pa Shun International Holdings Limited Announces Change of Principal Place of Business in Hong Kong

February 19, 2024 at 07:53 am EST

The board of directors of Pa Shun International Holdings Limited announced that the principal place of business of the company in Hong Kong has been changed to Suites 2601-2603, 26/F, Shui On Centre, 6-8 Harbour Road, Wanchai, Hong Kong with effect from 19 February 2024.

Latest news about Pa Shun International Holdings Limited

Pa Shun International Holdings Names Chairman, CEO	Apr. 03	MT
Pa Shun International Holdings Limited Announces Board Appointments	Apr. 02	CI
Pa Shun International Holdings Limited Announces the Appointment of Ma Qinghai as Chief Executive Officer	Apr. 02	CI
Pa Shun International Holdings Limited Approves Cessation of Feng Junzheng as Chief Executive Officer	Feb. 22	CI
Pa Shun International Holdings Limited Approves Management Retirements	Feb. 22	CI
Pa Shun International Holdings Limited Announces Change of Principal Place of Business in Hong Kong	Feb. 19	CI
Pa Shun Reports Narrower Loss For 2022	Jan. 10	MT
Pa Shun International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 09	CI
Hong Kong Court Dismisses Winding-Up Petition Against Pa Shun International	Nov. 23	MT
Pa Shun International Updates on Listing Resumption Plan	Nov. 13	MT
Pa Shun Swings to H1 Profit	Nov. 01	MT
Pa Shun International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	Nov. 01	CI
Pa Shun International Holdings Limited Announces Resignation of Shen Shun as Executive Director	23-10-26	CI
Pa Shun International Holdings Limited Announces Management Changes, Effective 1 October 2023	23-09-28	CI
Winding Up Petition Hearing Against Pa Shun International Adjourned to September	23-07-26	MT
Court Dismisses Pa Shun International’s Winding-Up Petition	23-06-29	MT
Court Adjourns Winding-Up Petition Against Pa Shun International to July	23-06-29	MT
Hong Kong High Court Adjourns Hearing for Winding-Up Petition Vs Pa Shun to June	23-05-15	MT
Hong Kong Court Adjourns Pa Shun Winding-Up Petition Hearing	23-05-10	MT
Hong Kong High Court Adjourns Hearing on Pa Shun Winding-Up Petition	23-04-25	MT
Pa Shun International Holdings Limited Announces Management Changes	23-03-28	CI
Pa Shun International Holdings Limited Announces Resignation of Zhang Xiongfeng as Non-Executive Director	23-03-16	CI
Pa Shun International Holdings Limited Announces Board and Committee Changes	23-03-10	CI
Pa Shun International Hit with Another Winding-Up Petition	23-03-09	MT
Winding Up Petition against Pa Shun International Gets Amended, Hearing Further Adjourned	23-03-07	MT

Chart Pa Shun International Holdings Limited

Duration

Period

Chart Pa Shun International Holdings Limited

More charts

Company Profile

Pa Shun International Holdings Limited, formerly Pa Shun Pharmaceutical International Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
PA SHUN INTERNATIONAL HOLDINGS LIMITED	+48.39%	8.69M
MCKESSON CORPORATION	+14.23%	69.5B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.2B
HUADONG MEDICINE CO., LTD	-20.55%	7.97B
SINOPHARM GROUP CO. LTD.	-4.06%	7.84B
H. LUNDBECK A/S	+2.26%	4.66B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	+1.41%	4.19B
GALENICA AG	-3.02%	3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+21.42%	3.62B